These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1153 related articles for article (PubMed ID: 29274868)

  • 61. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells.
    Magni L; Bouazzi R; Heredero Olmedilla H; Petersen PSS; Tozzi M; Novak I
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440697
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α
    Turaga RC; Sharma M; Mishra F; Krasinskas A; Yuan Y; Yang JJ; Wang S; Liu C; Li S; Liu ZR
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):161-179. PubMed ID: 32810598
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer.
    Tang D; Yuan Z; Xue X; Lu Z; Zhang Y; Wang H; Chen M; An Y; Wei J; Zhu Y; Miao Y; Jiang K
    Int J Cancer; 2012 May; 130(10):2337-48. PubMed ID: 21780106
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification.
    Wu YS; Looi CY; Subramaniam KS; Masamune A; Chung I
    Oncotarget; 2016 Jun; 7(24):36719-36732. PubMed ID: 27167341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer.
    Horioka K; Ohuchida K; Sada M; Zheng B; Moriyama T; Fujita H; Manabe T; Ohtsuka T; Shimamoto M; Miyazaki T; Mizumoto K; Oda Y; Nakamura M
    Int J Oncol; 2016 Apr; 48(4):1499-508. PubMed ID: 26846197
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility.
    Sada M; Ohuchida K; Horioka K; Okumura T; Moriyama T; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Nakamura M
    Cancer Lett; 2016 Mar; 372(2):210-8. PubMed ID: 26805763
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells.
    Masamune A; Kikuta K; Watanabe T; Satoh K; Hirota M; Hamada S; Shimosegawa T
    Gut; 2009 Apr; 58(4):550-9. PubMed ID: 19052021
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.
    Li N; Li Y; Li Z; Huang C; Yang Y; Lang M; Cao J; Jiang W; Xu Y; Dong J; Ren H
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271610
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
    Wong CW; Han HW; Tien YW; Hsu SH
    Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.
    Zhou L; Husted H; Moore T; Lu M; Deng D; Liu Y; Ramachandran V; Arumugam T; Niehrs C; Wang H; Chiao P; Ling J; Curran MA; Maitra A; Hung MC; Lee JE; Logsdon CD; Hwang RF
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355799
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells.
    Lenggenhager D; Amrutkar M; Sántha P; Aasrum M; Löhr JM; Gladhaug IP; Verbeke CS
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621293
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer.
    Zhang Y; Ware MB; Zaidi MY; Ruggieri AN; Olson BM; Komar H; Farren MR; Nagaraju GP; Zhang C; Chen Z; Sarmiento JM; Ahmed R; Maithel SK; El-Rayes BF; Lesinski GB
    Mol Cancer Ther; 2021 Jan; 20(1):150-160. PubMed ID: 33037138
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of stromal activin A in human pancreatic cancer and metastasis in mice.
    Mancinelli G; Torres C; Krett N; Bauer J; Castellanos K; McKinney R; Dawson D; Guzman G; Hwang R; Grimaldo S; Grippo P; Jung B
    Sci Rep; 2021 Apr; 11(1):7986. PubMed ID: 33846512
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression.
    Dunér S; Lopatko Lindman J; Ansari D; Gundewar C; Andersson R
    Pancreatology; 2010; 10(6):673-81. PubMed ID: 21242706
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12.
    Garg B; Giri B; Modi S; Sethi V; Castro I; Umland O; Ban Y; Lavania S; Dawra R; Banerjee S; Vickers S; Merchant NB; Chen SX; Gilboa E; Ramakrishnan S; Saluja A; Dudeja V
    Gastroenterology; 2018 Sep; 155(3):880-891.e8. PubMed ID: 29909021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.
    Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV
    Br J Cancer; 2016 Feb; 114(3):269-80. PubMed ID: 26766740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Key role of pancreatic stellate cells in pancreatic cancer.
    Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
    Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.